Thyrocare Technologies Limited (NSE:THYROCARE)

Thyrocare Technologies Revenue

Thyrocare Technologies had revenue of 2.71B INR in the quarter ending September 30, 2026, with 25.07% growth. This brings the company's total for the last twelve months to 9.30B, up 21.99% year-over-year. In the fiscal year ending March 31, 2026, Thyrocare Technologies had annual revenue of 8.29B with 20.61% growth.

• Revenue (ttm): 9.30B
• Revenue Growth: +21.99%
• P/S Ratio: 8.44
• Revenue / Employee: 4.88M
• Employees: 1,906
• Market Cap: 78.57B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Diagnostic Testing Services 7.73B 93.2%
• Imaging Services 531.40M 6.4%
• Others 33.70M 0.4%

By Geography

Chart

• India 8.26B 99.7%
• Tanzania 27.30M 0.3%

Fiscal year ended Mar 31, 2026 See the full Thyrocare Technologies breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	8.29B	1.42B	20.61%
Mar 31, 2025	6.87B	1.15B	20.19%
Mar 31, 2024	5.72B	452.20M	8.59%
Mar 31, 2023	5.27B	-621.90M	-10.56%
Mar 31, 2022	5.89B	942.40M	19.05%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error